相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Iron overload in MDS-pathophysiology, diagnosis, and complications
Norbert Gattermann et al.
ANNALS OF HEMATOLOGY (2011)
Interactions between erythropoietin and iron metabolism in anaemia of chronic disorders
G. Vreugdenhil et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Deferiprone-associated myelotoxicity
F. N. Al-Refaie et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Introduction of higher doses of deferasirox: better efficacy but not effective iron removal from the heart and increased risks of serious toxicities
George J. Kontoghiorghes
EXPERT OPINION ON DRUG SAFETY (2010)
MAINTENANCE OF NORMAL RANGE BODY IRON STORE LEVELS FOR UP TO 4.5 YEARS IN THALASSEMIA MAJOR PATIENTS USING DEFERIPRONE MONOTHERAPY
Annita Kolnagou et al.
HEMOGLOBIN (2010)
IDIOSYNCRATIC DRUG-INDUCED AGRANULOCYTOSIS: THE PARADIGM OF DEFERIPRONE
Charalampos Pontikoglou et al.
HEMOGLOBIN (2010)
Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts
Jaroslav Cermak et al.
LEUKEMIA RESEARCH (2009)
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
Hagop Kantarjian et al.
CANCER (2008)
Iron regulation and erythropoiesis
Elizabeta Nemeth
CURRENT OPINION IN HEMATOLOGY (2008)
Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy
Heather A. Leitch
LEUKEMIA RESEARCH (2007)
Deferiprone therapy for transfusional iron overload
AV Hoffbrand
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2005)
Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with β-thalassaemia major:: application of SQUID biomagnetic liver susceptometry
R Fischer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia
LJ Anderson et al.
LANCET (2002)
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients
A Ceci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Deferiprone versus deferoxamine in patients with thalassemia major: A randomized clinical trial
A Maggio et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?
DT Bowen et al.
LEUKEMIA RESEARCH (2001)
分享论文
